CTOR vs O · $105.2M cap vs P/E 50, rev $5.27B
Citius Oncology, Inc. (CTOR) versus Realty Income Corporation (O) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Realty Income Corporation (O) is a reit - retail company listed on NYSE.
CTOR does not have a complete income-statement cache yet.
Latest reported O revenue for 2024-12-31 was $5.27B. Net income was $867.3M. Revenue was up 29.2% from 2023-12-31 to 2024-12-31. O currently screens at market cap $56.48B and trailing P/E 49.6.
CTOR currently screens at market cap $105.2M. O currently screens at market cap $56.48B and trailing P/E 49.6.
Not investment advice. Open the CTOR and O stock pages for the full models.
Not investment advice.